Our Vision

We are the pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology and lean manufacturing

Our Purpose

We turn our customers' breakthrough innovations into viable therapies and manufacture the medicines of tomorrow

Our Values

Integrity
Collaboration
Passion
Accountability
Excellence

Making the Medicines of Tomorrow

As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow.

Founded in Switzerland in 1897, our company is the first and original CDMO. Today, we bring together a team of 18,500 colleagues across five continents to deliver integrated offerings that meet the complex needs of our global customer community.

Video Player is loading.

Current Time 0:00

Duration 3:02

Loaded: 5.44%

Stream Type LIVE

Remaining Time 3:02

Learn More About Us

Press contacts, information and resources including news releases, guidelines, images and videos.

Investor Relations

All information regarding our stock, financial results and investor relations events.

Find out more about our sustainability approach, targets and performance.

Explore our open positions across a range of disciplines, such as bioengineering and chemistry.

Our Offering

Integrated Biologics

Accelerate and de-risk the path to market with end-to-end offerings in mammalian development, manufacturing and licensing technologies.

Advanced Synthesis

With over 125 years of expertise in chemistry, we deliver high-quality small molecules, HPAPIs, and bioconjugates to support your drug development...

Specialized Modalities

We operate at the forefront of emerging mRNA, CGT and microbial technologies to pioneer customers’ breakthrough medicines.

Capsules & Health Ingredients

Explore our portfolio of innovative capsules and science-backed health ingredients for the pharmaceutical and nutraceutical markets.

Lonza’s stock

LONZA GROUP AG-REG
(LONN.SW: SIX Swiss Ex)

Last price:

CHF 555.00

Change today:

6.60 (%-1.18)

Investor Relations